A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010 by Liew, G et al.
A comparison of the causes
of blindness certiﬁcations in England
and Wales in working age adults
(16–64 years), 1999–2000 with 2009–2010
Gerald Liew,1,2 Michel Michaelides,1,3 Catey Bunce4
To cite: Liew G,
Michaelides M, Bunce C. A
comparison of the causes
of blindness certifications in
England and Wales in
working age adults
(16–64 years), 1999–2000
with 2009–2010. BMJ Open
2014;4:e004015.
doi:10.1136/bmjopen-2013-
004015
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2013-004015).
Received 12 September 2013
Revised 5 December 2013
Accepted 24 January 2014
For numbered affiliations see
end of article.
Correspondence to
Dr Gerald Liew;
gerald_liew@yahoo.com.au
ABSTRACT
Objectives: To report on the causes of blindness
certifications in England and Wales in working age
adults (16–64 years) in 2009–2010; and to compare
these with figures from 1999 to 2000.
Design: Analysis of the national database of blindness
certificates of vision impairment (CVIs) received by the
Certifications Office.
Setting and participants: Working age (16–
64 years) population of England and Wales.
Main outcome measures: Number and cause of
blindness certifications.
Results: The Certifications Office received 1756 CVIs for
blindness from persons aged between 16 and 64
inclusive between 1 April 2009 and 31 March 2010. The
main causes of blindness certifications were hereditary
retinal disorders (354 certifications comprising 20.2% of
the total), diabetic retinopathy/maculopathy (253
persons, 14.4%) and optic atrophy (248 persons,
14.1%). Together, these three leading causes accounted
for almost 50% of all blindness certifications. Between 1
April 1999 and 31 March 2000, the leading causes of
blindness certification were diabetic retinopathy/
maculopathy (17.7%), hereditary retinal disorders
(15.8%) and optic atrophy (10.1%).
Conclusions: For the first time in at least five decades,
diabetic retinopathy/maculopathy is no longer the leading
cause of certifiable blindness among working age adults in
England and Wales, having been overtaken by inherited
retinal disorders. This change may be related to factors
including the introduction of nationwide diabetic retinopathy
screening programmes in England and Wales and improved
glycaemic control. Inherited retinal disease, now
representing the commonest cause of certification in the
working age population, has clinical and research
implications, including with respect to the provision of care/
resources in the NHS and the allocation of research funding.
INTRODUCTION
England and Wales have collected data on
the number of blind people in the country
since 1851.1 2 From 1930 until 2003, the
causes of blindness have also been collected
through use of a designated certiﬁcate, the
BD8, which was completed by the examining
ophthalmologist.2 The BD8 was replaced in
England in September 2005 by the certiﬁcate
of vision impairment (CVI), and in Wales in
April 2007 by the equivalent form, the
CVI-W. One copy each of the CVI and CVI-W
is then sent to the Certiﬁcations Ofﬁce,
London for anonymised epidemiological
analysis. The Certiﬁcations Ofﬁce is currently
funded by the Royal National Institute for
the Blind (RNIB) and operates under the
auspices of the Royal College of
Ophthalmologists with CVI data under
Crown copyright, meaning the copyright is
owned by the British Government.
Although not compulsory, certiﬁcation
allows patients to be registered (ie, placed on
an ofﬁcial local council register) as either
severely sight impaired (blind) or sight
impaired (partially sighted), which then
permits access to certain state beneﬁts and
social service provisions. There is hence an
incentive for patients to be certiﬁed and
counted, providing an estimate, albeit imper-
fect,3 4 of the causes and burden of blindness
in England and Wales. The importance of
these data is highlighted by the fact that cer-
tiﬁcation ﬁgures have recently been adopted
in 2012 as an indicator for preventable sight
loss and included in the Public Health
Outcomes Framework.5 In this report, we
present the ﬁndings from an analysis of
working age blindness certiﬁcations from
Strengths and limitations of this study
▪ Strengths of the data include nationwide cover-
age, collection of uniform data fields with pre-
specified tick boxes, and clear and consistent
definitions of sight impairment.
▪ Limitations include comparisons across two
slightly different data collection forms.
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2009 to 2010 and compare these with ﬁgures from 1999
to 2000.6 Major changes in leading causes of blindness
certiﬁcation in this age group have occurred over this
period; subsequent publications will report on ﬁndings
in persons of other age groups.
METHODS
Details of data entry, collections and transmission have
been reported previously.6–8 Between 1 April 2009 and 31
March 2010, data were obtained from CVI forms, whereas
between 1 April 1999 and 31 March 2000, data were
obtained from BD8 forms. With regard to CVI forms, data
were transcribed from these paper-based forms into a data-
base at the Certiﬁcation Ofﬁce. Part C of the CVI form col-
lects information on the causes of visual loss and requires
the completing ophthalmologist to select from a list of
common diagnoses. More than one cause of visual loss
can be selected in which case the main cause should be
highlighted using either an asterisk or a circle. Guidelines
are provided to assist with this process when the main
cause is not evident. ‘Multiple’ causes are used where the
ophthalmologist completing the form has not indicated a
single main cause. Possible reasons for this selection
include differing causes in the two eyes, or more than one
cause within one eye, and the ophthalmologist is unable to
determine which contributes the most to the visual loss.
Causes for visual impairment were coded using the
International Classiﬁcation of Diseases (ICD)-9 codes and
grouped into disease categories as in previous reports.6–8
For 1999–2000, data were extracted from paper-based
BD8 forms in a similar fashion.6 Part 5 of the BD8 form
has 16 ﬁelds for medical information including one for
the main cause of visual loss and ﬁve for each eye for con-
tributory causes. For records where the main cause was
not ﬁlled, this ﬁeld was imputed wherever possible using
an algorithm published previously.8 In short, this algo-
rithm brought forward as the main cause the contributing
cause if any were so listed; if more than one contributory
cause was listed, the patient was listed as having ‘multiple
causes’. The main difference between data collected from
the CVI and BD8 forms is the number of certiﬁcations
with ‘multiple causes’ of visual impairment, which was
higher in the CVI forms.7 We have previously minimised
bias from this source by re-examining the certiﬁcates with
‘multiple causes’, extracting the contributory causes listed
and tabulating them with the main causes.7 We follow the
same procedure in this report.
Blindness was deﬁned according to criteria previously
described on the BD8 and CVI forms as either best cor-
rected visual acuity in the better eye of either (1) worse
than 3/60 or (2) worse than 6/60 with severely con-
stricted visual ﬁelds or (3) better than 6/60 with severely
constricted visual ﬁelds, particularly the inferior ﬁeld.
Analyses
Data regarding the main cause of visual impairment
were extracted from the forms and grouped into disease
categories as previously described.6–8 For CVI data, those
with ‘multiple causes’ or ‘no information on main
cause’ of visual impairment had contributory causes
extracted and listed, which were later combined with the
main causes. Pie and bar charts were used to graphically
illustrate the distribution of the main causes of visual
impairment. Proportions of blindness registrations due
to each cause are presented rather than adjusted inci-
dence rates in order to indicate the relative contribution
of each condition to the pool of vision impairment.
Currently, almost every grant application for diabetic ret-
inopathy projects starts with a statement that diabetic
retinopathy is the most common cause of visual loss in
the working age population—we present proportions of
blindness registrations to determine if this statement
remains valid. χ2 tests were performed to test differences
in proportions.
RESULTS
For the period 1 April 2009 to 31 March 2010, the
Certiﬁcations Ofﬁce received 1756 CVIs for blindness
from persons aged between 16 and 64 inclusive. This
compares with 1637 BD8 forms for blindness received
between 1 April 1999 and 31 March 2000, details of
which have been reported previously.8 Table 1 shows the
number of persons certiﬁed blind for each of the
disease categories. Hereditary retinal disorders, includ-
ing Stargardt disease and retinitis pigmentosa, formed
the largest category with 354 certiﬁcations comprising
20.2% of the total. Diabetic retinopathy/maculopathy
was the second largest cause of certiﬁable blindness with
253 persons (14.4%), followed by optic atrophy with 248
persons (14.1%). Together, these three leading causes
accounted for almost 50% of all blindness certiﬁcations
in the working age group. Glaucoma was responsible for
104 (5.9%) blindness certiﬁcations, followed by congeni-
tal abnormalities of the eye, which included congenital
cataracts and retinopathy of prematurity (89 certiﬁca-
tions, 5.1%). Multiple pathologies were listed for 242
persons (13.8%) and no information on the main cause
was listed for 42 persons (2.4%). When these categories
were examined for contributory causes, the most
common contributory causes recorded were glaucoma
(60 persons), diabetic retinopathy/maculopathy (56
persons) and optic atrophy (46 persons). Combining
the main and contributory causes resulted in small
changes in the overall proportion of certiﬁcations due to
speciﬁc causes, but did not change the relative rankings
of the top six causes of blindness (table 1). ‘Other con-
ditions’ comprised 150 certiﬁcations (8.5%), of which
the most common were malignant neoplasms of the
brain and nervous system (27 persons, 1.5%) and retinal
detachments (24 persons, 1.4%). Figure 1 shows the dis-
tribution of the causes of blindness certiﬁcations graph-
ically in a pie chart.
We next compared the main causes of blindness certi-
ﬁcations from 1999 to 2000 (n=1637) with the ﬁgures
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above from 2009 to 2010 (n=1756). The results are
shown graphically in ﬁgure 2. From 1999 to 2000, the
leading cause of blindness certiﬁcation was diabetic ret-
inopathy/maculopathy, which accounted for 290 certiﬁ-
cations (17.7%). By 2009–2010, this ﬁgure had
decreased to 253 (14.4%), and diabetic retinopathy/
maculopathy was now the second leading cause of blind-
ness certiﬁcation. This difference was statistically signiﬁ-
cant (p=0.009). In contrast, hereditary retinal disorders,
which were the second leading cause of blindness certiﬁ-
cation in 1999–2000, accounting for 258 cases (15.8% of
total), had increased to 354 cases (20.2%) by 2009–2010
and have now become the leading cause of certiﬁable
blindness in the working age group in England and
Wales. Optic atrophy remained the third leading cause
in 1999–2000 and 2009–2010 with an increase from 165
cases (10.1%) to 248 cases (14.1%), respectively.
A notable ﬁnding was that degeneration of the macula
and posterior pole, which accounted for 7.7% of blind-
ness registration in 1999–2000, had dropped in percent-
age terms and now accounted for only 3% by
2009–2010. Other causes of blindness registration
remained roughly similar for the two time periods.
DISCUSSION
This report provides updated estimates on the causes of
certiﬁable blindness in England and Wales in working
age adults. Three main diseases were responsible for
half of all certiﬁcations—hereditary retinal disorders
(20.2%), diabetic retinopathy/maculopathy (14.4%)
and optic atrophy (14.1%). A marked change has
occurred in the relative importance of these main
causes of blindness certiﬁcations since the last major
analysis in 1999–2000,6 with diabetic retinopathy/macu-
lopathy now no longer the leading cause of blindness in
working age adults. Since at least 1963,9 diabetic retinop-
athy/maculopathy has been the leading cause of
Table 1 Numbers of working age adults (age 16–64) with severe sight impairment (blindness) in England and Wales:
certifications 2009–2010
ICD-9
codes Diagnosis
Main cause
(% total)
Contributory cause
(% total)
Combined
(% total)
362.7 Hereditary retinal disorders 354 (20.2) 29 (6.6) 383 (20.0)
362/34 000 Diabetic retinopathy/maculopathy 253 (14.4) 56 (12.8) 309 (16.2)
377.1 Optic atrophy 248 (14.1) 46 (10.5) 294 (15.4)
365 Glaucoma 104 (5.9) 60 (13.7) 164 (8.6)
743–760 Congenital abnormalities of the eye 89 (5.1) 32 (7.3) 121 (6.3)
377.7 Disorders of the visual cortex 72 (4.1) 24 (5.5) 96 (5.0)
430–438 Cerebrovascular disease 56 (3.2) 21 (4.8) 77 (4.0)
362.5 Degeneration of the macula and posterior
pole
52 (3.0) 14 (3.2) 66 (3.5)
360.2 Myopia 49 (2.8) 23 (5.2) 72 (3.8)
370–371 Corneal disorders 45 (2.6) 34 (7.7) 79 (4.1)
– Multiple pathology 242 (13.8) - -
– Other conditions 150 (8.5) 100 (22.8) 250 (13.1)
– No information on main cause 42 (2.4) – –
Total 1756 439* 1911*
The ‘Main cause’ column lists the number of certifications with the corresponding diagnosis; the ‘Contributory cause’ column lists the
contributory causes in certifications from the ‘Multiple pathology’ and ‘No Information on main cause’ categories.
ICD, the International Classification of Disease.
*Including contributory causes. The total number of contributory causes is greater than the sum of ‘Multiple pathology’ and ‘No information
on main cause’ categories because persons can have between one and four contributory causes documented.
Figure 1 Main causes of severe sight impairment
(blindness) in England and Wales in working age adults (age
16–64): certifications 2009–2010.
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blindness among working age adults in England and
Wales; a similar situation exists in other developed coun-
tries such as the USA.10 Over the past decade, the pro-
portion of certiﬁcations for hereditary retinal disorders
has risen slowly,8 while that for diabetic retinopathy/
maculopathy has reduced, resulting in the two condi-
tions swapping rankings.
This report is not designed to identify the reasons
behind these changes or estimate the incidence of blind-
ness from diabetes. The prevalence of diabetes in the UK
is not known with certainty, with several limited general
practice surveys suggesting a range of between 1% and 2%
of the general population11–14; we are thus not able to esti-
mate the incidence of blindness from diabetes.
Nonetheless, available data suggest that the prevalence of
diabetes in England and Wales has increased over the
period in question,11 13 which would be expected to lead
to increased rates of blindness if other factors remained
constant. In this context, we speculate that several inter-
vening public health developments may have contributed
to the reduction in absolute and proportional rates of
registrable blindness from diabetes among working age
adults. Between 2003 and 2008, England and Wales intro-
duced nationwide diabetic retinopathy screening services
with the aim of reducing the incidence of blindness from
diabetic eye disease. These are known as the National
Health Service (NHS) Diabetic Eye Screening Program
(England)15 and Diabetic Retinopathy Screening Service
Wales (DRSSW),16 and these programmes annually screen
almost 2 million and 150 000 patients with diabetes,
respectively. Concurrent with these screening
programmes, in 2004 the Quality and Outcomes
Framework17 was introduced to incentivise general practi-
tioners in the UK to improve primary care management of
several conditions including diabetes. Several studies have
documented an improvement in the quality of care for dia-
betes since this was introduced,18 19 and the effort may
have contributed to the improvement in glycaemic control
documented since the late 1990s.17 20 The decline in the
absolute number and relative proportion of blindness cer-
tiﬁcations due to diabetic retinopathy/maculopathy
among working age adults since the introduction of these
public health measures may be an indicator of their effect-
iveness. Nonetheless, this remains speculative at present,
and such explanations should be read with caution.
Whether increased numbers of certiﬁcation for inher-
ited eye diseases reﬂect improved certiﬁcation of existing
sight impairment or a true increase in incidence of
these disorders is unclear. The progress made over the
last decade in molecular genetics/diagnostics and the
increasing avenues of research/clinical trials for inher-
ited retinal disease with widespread media coverage may
plausibly have resulted in higher community awareness
and increased clinic visits and thereby registration,4
without a true increase in incidence rates. An observa-
tion in favour of this scenario is that the numbers of
blindness certiﬁcation for optic atrophy have also
increased over the last decade, in tandem with those for
inherited retinal disease, while those for other non-
inherited conditions such as glaucoma have remained
fairly constant. Hereditary retinal diseases occur more
frequently in communities with a higher rate of
Figure 2 Ten-year change in
causes of severe sight
impairment (blindness) in
England and Wales in working
age adults (age 16–64):
certifications 1999–2000 and
2009–2010.
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consanguinity, and it is conceivable that increased rates
of immigration from countries where consanguinity is
more prevalent may have contributed to these ﬁndings,
though at this stage this remains speculative. Another
possibility is that diagnostic transfer or misclassiﬁcation
may have occurred, for example, where some cases of
hereditary retinal disorders may have been mislabelled
as ‘degeneration of macula and posterior pole’. In order
to explain the increase in hereditary retinal disorders,
this would have had to occur preferentially in 1999–2000
versus 2009–2010. However, misclassiﬁcation of diabetic
retinopathy/maculopathy as hereditary retinal disorders
is unlikely to occur given how different the conditions
are, and so would not explain the absolute reduction in
the number of certiﬁcations for blindness due to
diabetes.
These ﬁndings have implications for clinical care and
research budget allocation. A prolonged focus on preven-
tion and treatment of diabetic eye disease has most likely
contributed to the decline in blindness certiﬁcations from
this disorder among working age adults, and the rate is
expected to decline further with the recent National
Institute for Clinical Excellence (NICE) approval of ranibi-
zumab for treatment of diabetic maculopathy. Now that
hereditary retinal diseases comprise the leading cause of
blindness certiﬁcations in working age adults, an increased
focus on clinical management of these conditions (eg,
with low vision aids and visual rehabilitation) and greater
allocation of research funding to study these disorders
may be appropriate. Funding bodies may need to reassess
their funding priorities.
Strengths and limitations
Data from BD8 and CVI registrations represent some of
the best available epidemiological data on sight impair-
ment in England and Wales and are regarded as a major
public health indicator.5 Strengths of the data include
nationwide coverage, collection of uniform data ﬁelds
with prespeciﬁed tick boxes, and clear and consistent
deﬁnitions of sight impairment.
Limitations that should be highlighted include the fact
that blindness certiﬁcations are not equivalent to blindness
rates. This has been discussed previously,3 4 and it is esti-
mated that up to 53% of eligible patients may not be regis-
tered blind despite consultation with an ophthalmologist.7
However, arguments have been advanced that in time,
most patients eligible to be registered will in fact do so,7
and studies have shown a major increase in registration
rates with increasing clinic visits.4
Another caveat to these results is that some patients
who are certiﬁed blind may not always satisfy all of the
ofﬁcial criteria, with one study suggesting an inappropri-
ate blindness certiﬁcation rate of 23%.3 Such
inappropriate certiﬁcations may inﬂate the numbers
somewhat, but it should be borne in mind that the aim
of certiﬁcation is not to identify persons meeting rigid
clinical criteria but to identify and count those with sig-
niﬁcant visual impairment who may beneﬁt from state
assistance. Indeed, current guidelines for completion of
CVI forms state that the criteria should be interpreted
in the context of the patient’s functional status rather
than as strict cut-offs. Another precaution when inter-
preting these results is that the ﬁgures for the two time
periods were collated from different forms. The differ-
ences in these forms are discussed elsewhere,7 and one
of the main complications in comparing temporal
trends is the increase in the number of forms where a
main cause has not been identiﬁed. In the 1999–2000
dataset, which was derived from BD8, approximately 4%
of forms had ‘multiple pathology’; in the 2009–2010
dataset derived from CVI, this had increased to 14%.
This raised the possibility that diabetic retinopathy/
maculopathy may have been under-reported for the
2009–2010 period. We attempted to address this by
examining the contributory causes in those without a
main cause recorded and using these in place of the
missing main cause; this analysis resulted in only small
changes to the percentage of blindness due to each
cause and did not change the overall ranking of the top
six causes. This suggests that the rate of under-reporting
of main causes was similar for most categories and not
responsible for the shift in the leading causes of blind-
ness certiﬁcations.
In summary, this report found that three main causes
were responsible for half of all blindness certiﬁcations
among working age adults in England and Wales from
2009 to 2010—hereditary retinal disorders (20.2%), fol-
lowed by diabetic retinopathy/maculopathy (14.4%) and
optic atrophy (14.1%). This marks the ﬁrst time in
almost ﬁve decades that diabetic retinopathy/maculopa-
thy is no longer the leading cause of blindness in
working age adults, which may be related to the intro-
duction of nationwide public health measures in
England and Wales. The results have implications for
resource allocations for clinical care delivery and
research.
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